Table. Results From 4 Years of Full-Population Newborn Dried Blood Spot Screening in Missouria.
Lysosomal Storage Disease | Positive Screen Result | Confirmed Disorder | Genotypes of Unknown Significance or Onset | Pseudodeficiency | Carrier | False-Positive Findings (False-Positive Rate, %)b | Lost to Follow-up or Refused Further Testing | Incidence in Missouric | Positive Predictive Value,d % |
---|---|---|---|---|---|---|---|---|---|
Pompe | 161 | 32e | 9 | 31 | 39 | 48 (0.04) | 2 | 1:9625 | 26 |
Gaucher | 37 | 5 | 2 | 0 | 6 | 22 (0.01) | 2 | 1:61 600 | 20 |
Fabry | 179 | 94 | 6 | 1 | 0 | 66 (0.02) | 12 | 1:3277 | 60 |
MPS I | 133 | 2 | 2 | 71 | 8 | 45 (0.04) | 5 | 1:154 000 | 3 |
All | 510 | 133 | 19 | 103 | 53 | 181 | 21 | 1:2316 | NA |
Abbreviations: MPS I, mucopolysaccharidosis I; NA, not applicable.
Includes approximately 308 000 newborns undergoing screening. Unless otherwise indicated, data are expressed as numbers of newborns.
Calculated as those with pseudodeficient, carrier, and false-positive findings divided by the total number screened.
Includes only confirmed disorders.
Calculated as those with confirmed disorders and genotypes of unknown significance or onset divided by the number with positive screen results.
Includes 8 infantile and 24 late onset.